These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 8121717)
1. [Serodiagnosis of Pseudomonas aeruginosa infections in mucoviscidosis: comparative study of Western blotting, ELISA exotoxin A and ELISA phospholipase C]. Fournier C; Andre J; Marlier H; Guinet R; Gilly R Pathol Biol (Paris); 1993 Nov; 41(9):856-64. PubMed ID: 8121717 [TBL] [Abstract][Full Text] [Related]
2. Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis. Hollsing AE; Granström M; Vasil ML; Wretlind B; Strandvik B J Clin Microbiol; 1987 Oct; 25(10):1868-74. PubMed ID: 3117842 [TBL] [Abstract][Full Text] [Related]
3. Relation between antibody response to Pseudomonas aeruginosa exoproteins and colonization/infection in patients with cystic fibrosis. Granström M; Ericsson A; Strandvik B; Wretlind B; Pavlovskis OR; Berka R; Vasil ML Acta Paediatr Scand; 1984 Nov; 73(6):772-7. PubMed ID: 6441448 [TBL] [Abstract][Full Text] [Related]
4. Enzyme-linked immunosorbent assay for detection of antibodies to Pseudomonas aeruginosa exoproteins. Granström M; Wretlind B; Markman B; Pavlovskis OR; Vasil ML Eur J Clin Microbiol; 1985 Apr; 4(2):197-200. PubMed ID: 3924608 [TBL] [Abstract][Full Text] [Related]
5. Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: early detection by serology and assessment of risk factors. West SE; Zeng L; Lee BL; Kosorok MR; Laxova A; Rock MJ; Splaingard MJ; Farrell PM JAMA; 2002 Jun; 287(22):2958-67. PubMed ID: 12052125 [TBL] [Abstract][Full Text] [Related]
6. Pseudomonas aeruginosa serological analysis in young children with cystic fibrosis diagnosed through newborn screening. Hayes D; Farrell PM; Li Z; West SE Pediatr Pulmonol; 2010 Jan; 45(1):55-61. PubMed ID: 20025049 [TBL] [Abstract][Full Text] [Related]
7. Reaction of antibody in sera from cystic fibrosis patients with non-toxic forms of Pseudomonas aeruginosa exotoxin A. Klinger KW; Shuster CW; Klinger J Eur J Clin Microbiol; 1985 Apr; 4(2):201-6. PubMed ID: 3924609 [TBL] [Abstract][Full Text] [Related]
8. Pseudomonas aeruginosa antibody detection in cystic fibrosis patients. Trancassini M; De Vito D; Quattrucci S; Cipriani P New Microbiol; 1999 Apr; 22(2):85-9. PubMed ID: 10322606 [TBL] [Abstract][Full Text] [Related]
9. [Serology of anti-Pseudomonas aeruginosa and mucoviscidosis: diagnostic aid in the differentiation between colonization and infection]. Recule C; Croizé J; Coppéré C; Hirtz P; Goût JP; Le Noc P Pathol Biol (Paris); 1993 Mar; 41(3):249-54. PubMed ID: 8332395 [TBL] [Abstract][Full Text] [Related]
10. Reliable enzyme-linked immunosorbent assay systems for pathogenic factors of Pseudomonas aeruginosa alkaline proteinase, elastase, and exotoxin A: a comparison of methods for labeling detection antibodies with horseradish peroxidase. Shigematsu T; Suda N; Okuda K; Fukushima J Microbiol Immunol; 2007; 51(12):1149-59. PubMed ID: 18094533 [TBL] [Abstract][Full Text] [Related]
11. Immuno-modulatory functions of the type-3 secretion system and impacts on the pulmonary host defense: A role for ExoS of Pseudomonas aeruginosa in cystic fibrosis. Belmadi N; Wu Y; Touqui L Toxicon; 2018 Mar; 143():68-73. PubMed ID: 29339019 [TBL] [Abstract][Full Text] [Related]
12. Detection by enzyme-linked immunosorbent assays of antibody specific for Pseudomonas proteases and exotoxin A in sera from cystic fibrosis patients. Jagger KS; Robinson DL; Franz MN; Warren RL J Clin Microbiol; 1982 Jun; 15(6):1054-8. PubMed ID: 6809785 [TBL] [Abstract][Full Text] [Related]
13. Increased levels of IgG subclasses specific for Pseudomonas aeruginosa exoenzyme and polysaccharide antigens in chronically infected patients with cystic fibrosis. Albus A; Saalmann M; Tesch H; Pedersen SS; Döring G APMIS; 1989 Dec; 97(12):1146-8. PubMed ID: 2482060 [TBL] [Abstract][Full Text] [Related]
14. Pseudomonas aeruginosa exotoxin A antibodies in rapidly deteriorating chronic leg ulcers. Danielsen L; Westh H; Balselv E; Rosdahl VT; Döring G Lancet; 1996 Jan; 347(8996):265. PubMed ID: 8551911 [No Abstract] [Full Text] [Related]
15. Early immune response to the components of the type III system of Pseudomonas aeruginosa in children with cystic fibrosis. Corech R; Rao A; Laxova A; Moss J; Rock MJ; Li Z; Kosorok MR; Splaingard ML; Farrell PM; Barbieri JT J Clin Microbiol; 2005 Aug; 43(8):3956-62. PubMed ID: 16081936 [TBL] [Abstract][Full Text] [Related]
16. Immunization of cystic fibrosis patients with a Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine. Cryz SJ; Lang A; Rüdeberg A; Wedgwood J; Que JU; Fürer E; Schaad U Behring Inst Mitt; 1997 Feb; (98):345-9. PubMed ID: 9382759 [TBL] [Abstract][Full Text] [Related]
17. The role of serum Pseudomonas aeruginosa antibodies in the diagnosis and follow-up of cystic fibrosis. Doğru D; Pekcan S; Yalçın E; Ozçelik U; Kiper N; Gürcan N; Sener B Turk J Pediatr; 2013; 55(1):50-7. PubMed ID: 23692832 [TBL] [Abstract][Full Text] [Related]
18. Antibodies to proteases and exotoxin A of Pseudomonas aeruginosa in patients with cystic fibrosis: Demonstration by radioimmunoassay. Klinger JD; Straus DC; Hilton CB; Bass JA J Infect Dis; 1978 Jul; 138(1):49-8. PubMed ID: 98596 [TBL] [Abstract][Full Text] [Related]
19. Characterization of antibody response to Pseudomonas aeruginosa in patients with wound infections. Trafny EA; Grzybowski J; Patzer J; Popiel D; Wrembel-Wargocka J; Dzierzanowska D; Zawistowska-Marciniak I; Kobus K Microbiol Immunol; 1991; 35(6):435-42. PubMed ID: 1921760 [TBL] [Abstract][Full Text] [Related]
20. Isolation and characterizations of a novel recombinant scFv antibody against exotoxin A of Pseudomonas aeruginosa. Shadman Z; Farajnia S; Pazhang M; Tohidkia M; Rahbarnia L; Najavand S; Toraby S BMC Infect Dis; 2021 Mar; 21(1):300. PubMed ID: 33761869 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]